DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.
Full textbookMLAMSRAFoundationGP

Recognising palliative-care needs

Identify people who would benefit from palliative care on the basis of unmet need and deteriorating health, respond to urgent reversible problems, and coordinate proportionate generalist or specialist support without waiting for a precise prognosis.

!
Deterioration needing immediate assessment

Severe pain, breathlessness, haemorrhage, seizure, agitation, new neurological deficit or abrupt functional collapse may represent a treatable emergency as well as advanced illness.

Action: Assess ABCDE, relieve distress promptly and seek senior or emergency help while checking the person's known goals and treatment ceiling. Do not explain sudden decline as inevitable progression until proportionate assessment has considered reversible causes such as sepsis, retention, constipation, metabolic disturbance, medicine toxicity or obstruction.

Open the sections you need. The overview is shown first.
01Purpose and principlesWhat the treatment does and how it fits into care.

Palliative need is a multidimensional clinical state rather than a stage assigned only in the final days. A person may have burdensome symptoms, uncertainty, loss of function, family distress or repeated hospital treatment months or years before death. Early recognition creates time to control symptoms, clarify what matters, rationalise burdensome treatment and prepare for foreseeable crises. It does not remove access to rehabilitation, antibiotics, transfusion, dialysis or anticancer treatment when those interventions remain proportionate.

Recognition combines trajectory with present need. Useful signals include worsening performance, dependence in activities, reduced intake, frailty, recurrent unplanned admission, progressive disease despite optimal therapy and a growing mismatch between treatment burden and achievable benefit. Disease-specific indicators improve sensitivity, but none predicts an exact date of death. Explain prognosis as a range and review it as the trajectory changes.

The first assessment should establish the person's own priorities rather than translate clinician concerns directly into a referral. Ask about pain and other symptoms, emotional wellbeing, information preferences, social roles, finances, housing, spiritual or existential concerns and the ability of family or paid carers to sustain care. Determine which concern is most urgent, who will act on it and when response will be checked.

Generalist teams can provide core symptom management, honest communication and anticipatory coordination. Specialist palliative services should be involved when symptoms remain difficult despite appropriate first measures, opioid or route decisions are complex, conflict persists, psychological or spiritual distress is severe, or care crosses multiple services. Referral urgency follows instability and suffering, not a forecast alone.

UK workflow often begins with the clinician who notices change: a GP, ward team, disease specialist, community nurse or care-home professional. That clinician should not merely add a person to a register. They should communicate the trigger, immediate actions and clinical uncertainty to the usual coordinator, include the case in multidisciplinary review where available, and make sure the shared record contains an emergency contact and specific escalation advice. A register can prompt review but is not itself evidence that needs were assessed.

Non-malignant illness needs particular care because its course may alternate between severe crises and partial recovery. Heart failure, COPD, cirrhosis, renal failure and neurodegeneration require collaboration with the organ-specialist team so that diuresis, ventilation, drainage, dialysis decisions, rehabilitation or device care remain available when useful. Parallel planning can describe both a recovery pathway and what support will be provided if the next crisis does not reverse.

Key points

  • Palliative care is active care directed at quality of life, symptom relief, communication and support; it can begin while disease-directed treatment continues.
  • Need, not diagnosis or estimated survival, is the first-line trigger. Advanced heart, lung, neurological, renal and liver disease can create needs comparable with metastatic cancer.
  • Look for general deterioration, disease-specific progression, escalating service use, persistent symptoms, weight or function loss, treatment intolerance and caregiver strain.
  • A negative answer to the surprise question can prompt review, but it is neither a diagnostic test nor a requirement for referral.
  • First-line assessment is a direct holistic conversation covering physical symptoms, understanding, priorities, mood, relationships, practical concerns, spirituality and carer needs.
  • There is no single gold-standard biomarker. The clinical benchmark is repeated multidisciplinary assessment linked to action, shared records and review after change.
  • Generalist palliative care belongs to every clinician; specialist referral adds value for refractory symptoms, complex decisions, severe psychosocial distress or difficult coordination.
  • Recognition must not become therapeutic pessimism: investigate and treat reversible illness when the likely benefit matches the person's goals.
  • Record uncertainty honestly, identify who coordinates care and offer advance-care discussion without making planning forms a condition of receiving support.
02Indications, selection and cautionsWho may benefit, who needs urgent treatment and important alternatives.
General decline

Increasing dependence, weight loss, reduced intake, persistent fatigue, recurrent falls and falling performance across weeks or months should trigger a needs review.

Disease progression

Advancing malignancy, repeated decompensated organ failure, severe frailty or progressive neurological disability indicates rising risk even if the person intermittently recovers.

Health-service escalation

More unscheduled contacts, emergency admissions, prolonged stays or repeated rescue treatment often show that the current support plan no longer anticipates crises.

Unmet symptom burden

Pain, breathlessness, nausea, constipation, anxiety, fatigue or insomnia that limits ordinary life warrants active palliative assessment at any disease stage.

Decision complexity

Uncertainty about treatment benefit, disagreement about escalation or fear of discussing prognosis is itself a reason for skilled communication and multidisciplinary input.

Carer vulnerabilityRed flag

Exhaustion, poor health, competing responsibilities, anticipatory grief or inability to provide overnight care can threaten both patient safety and caregiver wellbeing.

Red flags requiring action

  • New limb weakness, sensory change or sphincter dysfunction in cancer may indicate metastatic spinal cord compression and needs urgent pathway activation.
  • Major bleeding, stridor, status epilepticus, severe hypercalcaemia or uncontrolled breathlessness requires immediate clinical treatment alongside palliative support.
  • Fluctuating attention or altered arousal suggests delirium; search for pain, infection, medicines, hypoxia, urinary retention, faecal loading and biochemical causes.
  • Repeated crisis attendance, rapidly falling performance or inability to take essential medicines signals an unstable plan even when no single symptom seems dramatic.
  • A distressed or exhausted caregiver, unsafe home environment or safeguarding concern can make the present care arrangement clinically unsafe.
  • Statements about wanting to die require compassionate exploration of symptoms, depression, coercion, immediate suicide risk and decision-making capacity rather than dismissal as expected sadness.
03Assessment before treatmentTests and checks that guide safe selection.
Investigation order

Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.

  1. 01
    First-line holistic needs conversationFirst stepFirst linePreferred
    Why
    Elicit physical, psychological, social, information, practical, cultural, spiritual and caregiver concerns in the patient's preferred order.
    Interpretation and limitations
    A structured prompt can prevent omissions, but the priority is the concern that matters most to the person and a named response rather than a total score.
  2. 02
    Functional and trajectory assessment
    Why
    Document mobility, self-care, intake, cognition, performance status, frailty and recent pattern of crises or recovery.
    Interpretation and limitations
    Trend is more informative than one measurement; rapid change increases urgency, while fluctuating organ failure requires contingency planning rather than false certainty.
  3. 03
    Proportionate clinical examination
    Why
    Identify symptom mechanisms, medication adverse effects and reversible contributors that could alter comfort, function or an agreed treatment decision.
    Interpretation and limitations
    Target examination to the clinical question and desired outcome; palliative intent neither mandates exhaustive testing nor justifies ignoring treatable pathology.
  4. 04
    Targeted laboratory or imaging tests
    Why
    Investigate suspected infection, obstruction, fracture, cord compression, hypercalcaemia, anaemia, renal failure or other actionable cause.
    Interpretation and limitations
    Order a test when its result could lead to treatment consistent with goals; avoid burdensome investigation whose possible results would not change care.
  5. 05
    Medication and route review
    Why
    Reconcile prescribed, non-prescribed and recently stopped medicines and check swallowing, adherence, organ function and rescue use.
    Interpretation and limitations
    Accumulation, withdrawal, interaction or an unusable oral route may explain deterioration and can often be corrected quickly.
  6. 06
    Multidisciplinary needs formulation
    Why
    Integrate medical, nursing, therapy, social-work, psychological, spiritual and primary-care information into one actionable plan.
    Interpretation and limitations
    This repeated shared formulation is the practical gold standard because it links changing needs to ownership, escalation criteria and review dates.
04Treatment approachPreparation, options, escalation and aftercare.
01IdentificationMove from trigger to needs-led planFirst stepProgression, functional decline, repeated crisis or a clinician, patient or carer concern suggests unmet palliative need.
  1. 1Ask permission for a holistic conversation, establish immediate priorities and assess symptoms, function, understanding, supports and caregiver capacity.
  2. 2Treat urgent reversible problems and start core generalist measures while deciding whether complexity or instability requires specialist palliative input.
  3. 3Document goals, responsible professionals, out-of-hours contacts, review timing and what change should prompt an earlier reassessment.
02Unstable symptomsEscalate suffering without delaying reliefEscalationSevere, rapidly changing or treatment-resistant symptoms are causing distress or repeated unscheduled care.
  1. 1Perform focused safety assessment, provide proportionate immediate relief and identify whether a disease emergency or medicine toxicity is contributing.
  2. 2Contact the appropriate acute and specialist palliative teams, giving current treatments, organ function, goals, response and an explicit clinical question.
  3. 3Create a same-day route and rescue plan, explain it to the patient and carers and confirm who will review effectiveness and adverse effects.
03Ongoing reviewTrack trajectory and preserve reversibilityPalliative needs have been identified but illness and treatment options continue to evolve.
  1. 1Review symptoms, performance, cognition, nutrition, priorities and family capacity after each material clinical or social change.
  2. 2Reconsider disease-directed and preventive treatments individually according to likely benefit, burden, time to benefit and current values.
  3. 3Offer advance planning and emergency-care discussion at the person's pace, share agreed records with consent and avoid assuming that prognosis is fixed.
04Equitable accessFind needs hidden by service barriersLanguage, disability, homelessness, learning difference, deprivation or a non-cancer diagnosis may be obscuring deterioration or preventing referral.
  1. 1Use professional interpretation, accessible assessment and information from trusted cross-sector professionals while preserving direct patient involvement.
  2. 2Identify which barrier affects attendance, medicine access, housing, communication or care provision and assign an operational remedy rather than labelling non-engagement.
  3. 3EscalationEscalate unmet clinical complexity through the same needs-based thresholds, document reasonable adjustments and review whether the planned service was actually reachable.
05Complications, monitoring and follow-upAdverse effects, response and longer-term review.
  • Measure change in the person's priority symptom or function, not merely whether a referral was made.
  • Reassess after admission, new dependency, treatment failure, cognitive change, caregiver breakdown or increasing rescue use.
  • Confirm that advice, equipment and prescribed rescue treatment can actually be obtained during nights and weekends.
  • Review whether generalist actions have worked and escalate persistent complexity rather than repeatedly documenting the same unmet need.
  • Audit access across non-cancer diagnoses, learning disability, language, deprivation, homelessness and care-home residence to detect inequity.
  • Check patient and caregiver understanding of whom to contact, which changes are expected and which require urgent help.
06Special situationsVariants, exceptions and circumstances that change the usual approach.

Need can precede prognosis

A person can benefit from symptom, psychological and planning support while life expectancy remains uncertain and active treatment is ongoing.

Triggers start assessment

Indicator tools and the surprise question improve recognition only when a clinician then explores individual needs and acts on them.

Referral is not abandonment

Specialist palliative involvement adds expertise and usually works alongside the existing disease team rather than replacing it.

Uncertainty permits planning

Contingency plans can acknowledge several plausible trajectories and specify what to do if recovery, crisis or further decline occurs.

Carers are separate patients

Their willingness, health and support needs require direct assessment and must not be inferred from family presence alone.

07Common pitfallsFrequent interpretation and management errors.
  1. 01

    Restricting palliative care to cancer or to the final days of life.

  2. 02

    Treating a screening prompt as a definitive prognostic instrument.

  3. 03

    Making referral before asking the patient what help they want.

  4. 04

    Calling deterioration expected without checking actionable reversible causes.

  5. 05

    Equating palliative intent with stopping every disease-directed treatment.

  6. 06

    Recording needs without assigning an owner and review date.

  7. 07

    Assuming a present relative is willing or able to provide continuous care.

  8. 08

    Withholding prognosis discussion from a patient who wants information because relatives requested secrecy.

Practice

Two practice questions

Question 1 of 20 correct
Palliative and end-of-life careOriginal SBA

Needs-led palliative recognition

A patient with advanced heart failure has frequent admissions, worsening breathlessness and an exhausted spouse but is still receiving disease-modifying treatment. What is the best next step?

Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom